AstraZeneca announced the launch of Dutoprol (metoprolol succinate extended-release/hydrochlorothiazide) tablets, the once-daily antihypertensive agent that contains the active ingredient of Toprol XL (metoprolol succinate) plus a low-dose diuretic.
AstraZeneca has also created Dutoprol Direct, a direct-to-patient mail-order program, which may offer additional savings to patients beyond the retail pharmacy price
Dutoprol is a combination of a cardioselective β1-blocker and a thiazide diuretic indicated to treat hypertension. It is available in 25mg/12.5mg, 50mg/12.5mg, and 100mg/12.5mg dosage strengths in a 30-count bottle.
For more information call (800) 637-3616 or visit www.dutoprol.com.